ГЕДУЛИН Бронислава (US),ГРЕЙ Майкл (US),О'ДОННЕЛЛ Найалл (US),КЕЛЛЕР Брэдли Т. (US),ОДОННЕЛЛ Найалл (US)
申请号：
RU2015139731
公开号：
RU2015139731A
申请日:
2014.03.14
申请国别(地区):
RU
年份:
2017
代理人:
摘要：
Provided herein are methods of treating or ameliorating primary sclerosing cholangitis and inflammatory bowel disease by administering to an individual in need thereof a therapeutically effective amount of an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTI) or a pharmaceutically acceptable salt thereof. Also provided are methods for treating or ameliorating primary sclerosing cholangitis comprising administering to an individual in need thereof a therapeutically effective amount of ASBTI or a pharmaceutically acceptable salt thereof.
